French university combining combustion science, healthcare robotics, and astrobiology research across 21 H2020 projects with 417 partners in 44 countries.
Université d'Orléans is a French public university with research strengths spanning biomedical engineering, combustion science, energy systems, and planetary sciences. Their labs develop smartphone-based thermal diagnostics for diabetic patients, secure indoor robotic fleets for healthcare logistics, and study hydrogen and ammonia combustion for flexible power plants. They also conduct fundamental research in astrobiology (Mars biosignatures), atmospheric chemistry, and advanced materials — often contributing specialized experimental or modelling expertise to large European consortia.
Coordinated STANDUP (smartphone thermal analysis for diabetic foot), ENDORSE and RESPECT (secure indoor robotic fleets for healthcare), and participated in PROPHETIC (remote patient management).
Contributed to FUN-PM (nanoparticle emissions from engines), FLEXnCONFU (hydrogen/ammonia combustion in power plants), ARENHA (ammonia energy storage), and AMHYCO (hydrogen combustion risk management).
Participated in FLEXnCONFU (power-to-hydrogen/ammonia), ARENHA (ammonia reactors and electrosynthesis), and AMHYCO (hydrogen combustion safety).
Coordinates BIOMAMA (€2M ERC Starting Grant) investigating biosignatures in Martian materials using extremophile and chemolithotroph analysis.
Coordinated PERSEUS (pulsed jet actuators for turbulent flow separation control) and contributed to EUROfusion (fusion energy research).
Participated in Olive-Net (bioactive compounds from Olea europaea for food, cosmetics, pharma) and MARSU (marine atmospheric chemistry).
In the early H2020 period (2014–2018), Orléans focused on natural product chemistry (olive bioactives, nutraceuticals), marine atmospheric science, and thermomechanical modelling of refractory materials. From 2019 onward, the university pivoted strongly toward applied digital health (secure robotics, cybersecurity for healthcare) and energy transition technologies (hydrogen/ammonia combustion, power-to-X). The 2022 ERC Starting Grant in astrobiology signals a new fundamental science direction alongside these applied thrusts.
Orléans is building a dual identity — applied digital health systems on one side and clean combustion/hydrogen energy on the other — with a rising astrobiology programme that could attract space-sector partnerships.
Orléans most frequently joins projects as a third party or specialist participant (15 of 21 projects), contributing targeted experimental or modelling expertise to large consortia. However, they coordinate actively when the topic aligns with their core labs — five coordinated projects in healthcare robotics, flow dynamics, and astrobiology. With 417 unique partners across 44 countries, they operate as a broadly connected hub rather than relying on repeat partnerships, making them easy to integrate into new consortia.
Extensively networked with 417 unique consortium partners across 44 countries, reflecting both their third-party roles in large joint programmes (EUROfusion, EURAD) and their own coordinated MSCA-RISE networks. Their reach is genuinely pan-European with global connections.
What sets Orléans apart is the unusual combination of combustion science expertise with healthcare technology — labs that understand thermal imaging for engine emissions also apply thermography to diabetic foot diagnostics. Their willingness to serve as third-party specialists means they bring deep, focused contributions without overhead, making them a low-risk addition to consortia. The recent €2M ERC grant in astrobiology adds a distinctive research pillar rarely found at a regional French university.
